A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

Brief description of study

The main goal of this study is to determine if limited surgery or high dose precision radiation is better in patients who are at an elevated risk for surgical complications with early stage lung cancer.


Clinical Study Identifier: s16-02247
ClinicalTrials.gov Identifier: NCT02468024
Principal Investigator: Benjamin Cooper.


If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.